Literature DB >> 23803069

Inhibitory effects of syk transfection on lung cancer cell invasion.

Chuan-Liang Peng1, Ying Zhang, Qi-Feng Sun, Yun-Peng Zhao, Ying-Tao Hao, Xiao-Gang Zhao, Bo Cong.   

Abstract

OBJECTIVE: Spleen tyrosine kinase (Syk) is closely related to tumor invasion and metastasis, and has been shown to have potential inhibitory effects in tumors. In this study, we constructed a eukaryotic expression vector for Syk and analyzed its effects on invasive ability of the A549 non-small cell lung cancer cell line in vitro.
METHODS: A fragment of Syk was obtained by RT-PCR from human lung cancer cells and cloned into the expression vector pLNCXSyk. After restriction endonuclease digestion, PCR and DNA sequencing confirmation, the recombinant Syk expression plasmid was transfected into A549 human lung cancer cells using lipofectamine protocols. After selection, the cells stably expressed Syk. Detection of Syk expression of the cells by RT-PCR, and invasive ability were examined.
RESULTS: The eukaryotic expression plamid pLNCXSyk was constructed and expressed stably in the A549 human lung cancer cells. The RT-PCR results showed that Syk mRNA expression was upregulated significantly (P<0.05). Lower invasion through a basal membrane were apparent after transfection (P<0.05).
CONCLUSIONS: A eukaryotic expression plasmid to cause Syk expression in lung cancer cells can obviously inhibit their invasive ability in vitro.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23803069     DOI: 10.7314/apjcp.2013.14.5.3001

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  [Spleen tyrosine kinase inhibits proliferation and promotes apoptosis of colorectal cancer cells in vitro via regulating Fra-1].

Authors:  Zuo-Wu Xi; Wei-Tao Liang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

2.  BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

Authors:  Tess Orvis; Austin Hepperla; Vonn Walter; Ian J Davis; Bernard Weissman; Shujie Song; Jeremy Simon; Joel Parker; Matthew D Wilkerson; Nisarg Desai; Michael B Major; D Neil Hayes
Journal:  Cancer Res       Date:  2014-08-12       Impact factor: 12.701

3.  Prognostic value of spleen tyrosine kinase in human solid tumors.

Authors:  Beibei Ni; Shi Li; Yang Liu; Yuqian Huang; Zesong Li
Journal:  Onco Targets Ther       Date:  2018-06-08       Impact factor: 4.147

4.  Expression of Syk and MAP4 proteins in ovarian cancer.

Authors:  Siwei Zhang; Suha Deen; Sarah J Storr; Anqi Yao; Stewart G Martin
Journal:  J Cancer Res Clin Oncol       Date:  2019-02-08       Impact factor: 4.553

5.  Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression.

Authors:  Beibei Ni; Jun Hu; Dianke Chen; Li Li; Daici Chen; Jianping Wang; Lei Wang
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.